PRLA PHARMA
associated with 1 other trademarks
Pharmaceutical to act as a prolactin receptor antagonist to treat or prevent diseases, namely, lymphangioleiomymatosis and cancer

Words that describe this trademark:

receptor antagonist  prolactin receptor  prevent diseases  pharmaceutical act  treat  cancer  act  antagonist  diseases 

Serial Number:

86758012

Mark:

PRLA PHARMA

Status:

Abandoned-No Statement of Use filed

Status Date:

12-10-2018

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical to act as a prolactin receptor antagonist to treat or prevent diseases, namely, lymphangioleiomymatosis and cancer

Mark Description:

The mark consists of the letter string "PrlA" in stylized font, with the letters "P" and "A" in upper case and the letters "r" and "l" in lower case, all appearing horizontally within a shaded oval, the letter "A" being separated from the letter "l" by a vertical dotted line extending from the top of the oval to the bottom of the oval, and all of the foregoing appearing above the word "PHARMA" in upper case in a different stylized font.

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

03-08-2016

Mark Drawing Status:

Design plus Words, Letters, and/or Numbers

Abandon Date:

12-10-2018

Business Name:

FLECKMAN & MCGLYNN, PLLC

Correspondent Name:

Recent Trademark filings by this company